nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—Headache—Vinblastine—testicular cancer	0.00162	0.00162	CcSEcCtD
Dantrolene—Leukopenia—Etoposide—testicular cancer	0.00162	0.00162	CcSEcCtD
Dantrolene—Abdominal pain—Dactinomycin—testicular cancer	0.00161	0.00161	CcSEcCtD
Dantrolene—Body temperature increased—Dactinomycin—testicular cancer	0.00161	0.00161	CcSEcCtD
Dantrolene—Fatigue—Ifosfamide—testicular cancer	0.00161	0.00161	CcSEcCtD
Dantrolene—Anaphylactic shock—Cisplatin—testicular cancer	0.00161	0.00161	CcSEcCtD
Dantrolene—Hypersensitivity—Bleomycin—testicular cancer	0.00161	0.00161	CcSEcCtD
Dantrolene—Pain—Ifosfamide—testicular cancer	0.0016	0.0016	CcSEcCtD
Dantrolene—Constipation—Ifosfamide—testicular cancer	0.0016	0.0016	CcSEcCtD
Dantrolene—Cardiac failure—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Dantrolene—Thrombocytopenia—Cisplatin—testicular cancer	0.00158	0.00158	CcSEcCtD
Dantrolene—Tachycardia—Cisplatin—testicular cancer	0.00157	0.00157	CcSEcCtD
Dantrolene—Asthenia—Bleomycin—testicular cancer	0.00157	0.00157	CcSEcCtD
Dantrolene—Convulsion—Etoposide—testicular cancer	0.00157	0.00157	CcSEcCtD
Dantrolene—Hypertension—Etoposide—testicular cancer	0.00156	0.00156	CcSEcCtD
Dantrolene—Pain in extremity—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Dantrolene—Diplopia—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Dantrolene—Hyperhidrosis—Cisplatin—testicular cancer	0.00156	0.00156	CcSEcCtD
Dantrolene—Pruritus—Bleomycin—testicular cancer	0.00155	0.00155	CcSEcCtD
Dantrolene—Feeling abnormal—Ifosfamide—testicular cancer	0.00154	0.00154	CcSEcCtD
Dantrolene—Eosinophilia—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Dantrolene—Nausea—Vinblastine—testicular cancer	0.00154	0.00154	CcSEcCtD
Dantrolene—Anorexia—Cisplatin—testicular cancer	0.00154	0.00154	CcSEcCtD
Dantrolene—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00153	0.00153	CcSEcCtD
Dantrolene—Discomfort—Etoposide—testicular cancer	0.00152	0.00152	CcSEcCtD
Dantrolene—Hypersensitivity—Dactinomycin—testicular cancer	0.0015	0.0015	CcSEcCtD
Dantrolene—Confusional state—Etoposide—testicular cancer	0.00149	0.00149	CcSEcCtD
Dantrolene—Muscular weakness—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Dantrolene—Urticaria—Ifosfamide—testicular cancer	0.00149	0.00149	CcSEcCtD
Dantrolene—Abdominal pain—Ifosfamide—testicular cancer	0.00148	0.00148	CcSEcCtD
Dantrolene—Body temperature increased—Ifosfamide—testicular cancer	0.00148	0.00148	CcSEcCtD
Dantrolene—Anaphylactic shock—Etoposide—testicular cancer	0.00148	0.00148	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00147	0.00147	CcSEcCtD
Dantrolene—Asthenia—Dactinomycin—testicular cancer	0.00146	0.00146	CcSEcCtD
Dantrolene—Dysphagia—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Dantrolene—Thrombocytopenia—Etoposide—testicular cancer	0.00145	0.00145	CcSEcCtD
Dantrolene—Tachycardia—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Dantrolene—Eosinophilia—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Dantrolene—Hyperhidrosis—Etoposide—testicular cancer	0.00143	0.00143	CcSEcCtD
Dantrolene—Anorexia—Etoposide—testicular cancer	0.00141	0.00141	CcSEcCtD
Dantrolene—Decreased appetite—Cisplatin—testicular cancer	0.0014	0.0014	CcSEcCtD
Dantrolene—Diarrhoea—Dactinomycin—testicular cancer	0.0014	0.0014	CcSEcCtD
Dantrolene—Vomiting—Bleomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Dantrolene—Drowsiness—Methotrexate—testicular cancer	0.00139	0.00139	CcSEcCtD
Dantrolene—Depression—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Dantrolene—Rash—Bleomycin—testicular cancer	0.00138	0.00138	CcSEcCtD
Dantrolene—Pain—Cisplatin—testicular cancer	0.00138	0.00138	CcSEcCtD
Dantrolene—Dermatitis—Bleomycin—testicular cancer	0.00138	0.00138	CcSEcCtD
Dantrolene—Hypersensitivity—Ifosfamide—testicular cancer	0.00138	0.00138	CcSEcCtD
Dantrolene—Muscular weakness—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Dantrolene—Renal failure—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Dantrolene—Dysphagia—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Dantrolene—Pollakiuria—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Dantrolene—Asthenia—Ifosfamide—testicular cancer	0.00134	0.00134	CcSEcCtD
Dantrolene—Eosinophilia—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Dantrolene—Sweating—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Dantrolene—Feeling abnormal—Cisplatin—testicular cancer	0.00133	0.00133	CcSEcCtD
Dantrolene—Pruritus—Ifosfamide—testicular cancer	0.00132	0.00132	CcSEcCtD
Dantrolene—Haematuria—Methotrexate—testicular cancer	0.00132	0.00132	CcSEcCtD
Dantrolene—Somnolence—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Dantrolene—Nausea—Bleomycin—testicular cancer	0.0013	0.0013	CcSEcCtD
Dantrolene—Drowsiness—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Dantrolene—Vomiting—Dactinomycin—testicular cancer	0.0013	0.0013	CcSEcCtD
Dantrolene—Rash—Dactinomycin—testicular cancer	0.00129	0.00129	CcSEcCtD
Dantrolene—Decreased appetite—Etoposide—testicular cancer	0.00128	0.00128	CcSEcCtD
Dantrolene—Diarrhoea—Ifosfamide—testicular cancer	0.00128	0.00128	CcSEcCtD
Dantrolene—Renal failure—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Dantrolene—Body temperature increased—Cisplatin—testicular cancer	0.00127	0.00127	CcSEcCtD
Dantrolene—Fatigue—Etoposide—testicular cancer	0.00127	0.00127	CcSEcCtD
Dantrolene—Pain—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Dantrolene—Constipation—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Dantrolene—Haemoglobin—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Dantrolene—Haemorrhage—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Dantrolene—Hepatitis—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Dantrolene—Sweating—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Dantrolene—Pollakiuria—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Dantrolene—Haematuria—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Dantrolene—Dizziness—Ifosfamide—testicular cancer	0.00124	0.00124	CcSEcCtD
Dantrolene—Feeling abnormal—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Dantrolene—Nausea—Dactinomycin—testicular cancer	0.00121	0.00121	CcSEcCtD
Dantrolene—Gastrointestinal pain—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Dantrolene—Drowsiness—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Dantrolene—Visual impairment—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Dantrolene—Vomiting—Ifosfamide—testicular cancer	0.00119	0.00119	CcSEcCtD
Dantrolene—Hypersensitivity—Cisplatin—testicular cancer	0.00119	0.00119	CcSEcCtD
Dantrolene—Renal failure—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Dantrolene—Rash—Ifosfamide—testicular cancer	0.00118	0.00118	CcSEcCtD
Dantrolene—Dermatitis—Ifosfamide—testicular cancer	0.00118	0.00118	CcSEcCtD
Dantrolene—Urticaria—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Dantrolene—Haemoglobin—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Dantrolene—Body temperature increased—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Dantrolene—Abdominal pain—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Dantrolene—Haemorrhage—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Dantrolene—Hepatitis—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Dantrolene—Asthenia—Cisplatin—testicular cancer	0.00116	0.00116	CcSEcCtD
Dantrolene—Sweating—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Dantrolene—Haematuria—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Dantrolene—Visual impairment—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Dantrolene—Chills—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Dantrolene—Nausea—Ifosfamide—testicular cancer	0.00111	0.00111	CcSEcCtD
Dantrolene—Diarrhoea—Cisplatin—testicular cancer	0.0011	0.0011	CcSEcCtD
Dantrolene—Hypersensitivity—Etoposide—testicular cancer	0.00109	0.00109	CcSEcCtD
Dantrolene—Erythema—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Dantrolene—Flushing—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Dantrolene—Asthenia—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Dantrolene—Back pain—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Dantrolene—Chills—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Dantrolene—Pruritus—Etoposide—testicular cancer	0.00105	0.00105	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Dantrolene—Vomiting—Cisplatin—testicular cancer	0.00103	0.00103	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Dantrolene—Rash—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Dantrolene—Dermatitis—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Dantrolene—Erythema—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Dantrolene—Diarrhoea—Etoposide—testicular cancer	0.00101	0.00101	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Dantrolene—Anaemia—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Dantrolene—Tension—Epirubicin—testicular cancer	0.000996	0.000996	CcSEcCtD
Dantrolene—Dysgeusia—Epirubicin—testicular cancer	0.000994	0.000994	CcSEcCtD
Dantrolene—Nervousness—Epirubicin—testicular cancer	0.000986	0.000986	CcSEcCtD
Dantrolene—Back pain—Epirubicin—testicular cancer	0.000981	0.000981	CcSEcCtD
Dantrolene—Malaise—Methotrexate—testicular cancer	0.000978	0.000978	CcSEcCtD
Dantrolene—Dizziness—Etoposide—testicular cancer	0.000977	0.000977	CcSEcCtD
Dantrolene—Leukopenia—Methotrexate—testicular cancer	0.000971	0.000971	CcSEcCtD
Dantrolene—Chills—Doxorubicin—testicular cancer	0.000968	0.000968	CcSEcCtD
Dantrolene—Nausea—Cisplatin—testicular cancer	0.000958	0.000958	CcSEcCtD
Dantrolene—Vision blurred—Epirubicin—testicular cancer	0.000956	0.000956	CcSEcCtD
Dantrolene—Ill-defined disorder—Epirubicin—testicular cancer	0.000941	0.000941	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—testicular cancer	0.000939	0.000939	CcSEcCtD
Dantrolene—Vomiting—Etoposide—testicular cancer	0.000939	0.000939	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—testicular cancer	0.000939	0.000939	CcSEcCtD
Dantrolene—Anaemia—Epirubicin—testicular cancer	0.000938	0.000938	CcSEcCtD
Dantrolene—Rash—Etoposide—testicular cancer	0.000931	0.000931	CcSEcCtD
Dantrolene—Dermatitis—Etoposide—testicular cancer	0.000931	0.000931	CcSEcCtD
Dantrolene—Headache—Etoposide—testicular cancer	0.000925	0.000925	CcSEcCtD
Dantrolene—Myalgia—Methotrexate—testicular cancer	0.000923	0.000923	CcSEcCtD
Dantrolene—Tension—Doxorubicin—testicular cancer	0.000921	0.000921	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—testicular cancer	0.000919	0.000919	CcSEcCtD
Dantrolene—Malaise—Epirubicin—testicular cancer	0.000915	0.000915	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—testicular cancer	0.000912	0.000912	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—testicular cancer	0.000912	0.000912	CcSEcCtD
Dantrolene—Leukopenia—Epirubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Dantrolene—Confusional state—Methotrexate—testicular cancer	0.000892	0.000892	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—testicular cancer	0.000885	0.000885	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—testicular cancer	0.000885	0.000885	CcSEcCtD
Dantrolene—Convulsion—Epirubicin—testicular cancer	0.000879	0.000879	CcSEcCtD
Dantrolene—Nausea—Etoposide—testicular cancer	0.000878	0.000878	CcSEcCtD
Dantrolene—Hypertension—Epirubicin—testicular cancer	0.000876	0.000876	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—testicular cancer	0.000871	0.000871	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—testicular cancer	0.000868	0.000868	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—testicular cancer	0.000866	0.000866	CcSEcCtD
Dantrolene—Myalgia—Epirubicin—testicular cancer	0.000864	0.000864	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—testicular cancer	0.000855	0.000855	CcSEcCtD
Dantrolene—Discomfort—Epirubicin—testicular cancer	0.000854	0.000854	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—testicular cancer	0.000847	0.000847	CcSEcCtD
Dantrolene—Dry mouth—Epirubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—testicular cancer	0.000843	0.000843	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—testicular cancer	0.00084	0.00084	CcSEcCtD
Dantrolene—Confusional state—Epirubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Dantrolene—Anaphylactic shock—Epirubicin—testicular cancer	0.000828	0.000828	CcSEcCtD
Dantrolene—Convulsion—Doxorubicin—testicular cancer	0.000813	0.000813	CcSEcCtD
Dantrolene—Thrombocytopenia—Epirubicin—testicular cancer	0.000811	0.000811	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—testicular cancer	0.000811	0.000811	CcSEcCtD
Dantrolene—Tachycardia—Epirubicin—testicular cancer	0.000808	0.000808	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000806	0.000806	CcSEcCtD
Dantrolene—Hyperhidrosis—Epirubicin—testicular cancer	0.000801	0.000801	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—testicular cancer	0.0008	0.0008	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—testicular cancer	0.000799	0.000799	CcSEcCtD
Dantrolene—Discomfort—Doxorubicin—testicular cancer	0.00079	0.00079	CcSEcCtD
Dantrolene—Anorexia—Epirubicin—testicular cancer	0.000789	0.000789	CcSEcCtD
Dantrolene—Somnolence—Methotrexate—testicular cancer	0.000787	0.000787	CcSEcCtD
Dantrolene—Dry mouth—Doxorubicin—testicular cancer	0.000782	0.000782	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—testicular cancer	0.000779	0.000779	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—testicular cancer	0.000769	0.000769	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—testicular cancer	0.000763	0.000763	CcSEcCtD
Dantrolene—Pain—Methotrexate—testicular cancer	0.000757	0.000757	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000754	0.000754	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—testicular cancer	0.00075	0.00075	CcSEcCtD
Dantrolene—Insomnia—Epirubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—testicular cancer	0.000748	0.000748	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—testicular cancer	0.000741	0.000741	CcSEcCtD
Dantrolene—Somnolence—Epirubicin—testicular cancer	0.000736	0.000736	CcSEcCtD
Dantrolene—Anorexia—Doxorubicin—testicular cancer	0.00073	0.00073	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—testicular cancer	0.000729	0.000729	CcSEcCtD
Dantrolene—Dyspepsia—Epirubicin—testicular cancer	0.000729	0.000729	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methotrexate—testicular cancer	0.000724	0.000724	CcSEcCtD
Dantrolene—Decreased appetite—Epirubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Dantrolene—Fatigue—Epirubicin—testicular cancer	0.000714	0.000714	CcSEcCtD
Dantrolene—Pain—Epirubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
Dantrolene—Constipation—Epirubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
Dantrolene—Urticaria—Methotrexate—testicular cancer	0.000703	0.000703	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—testicular cancer	0.0007	0.0007	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—testicular cancer	0.0007	0.0007	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000698	0.000698	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—testicular cancer	0.000693	0.000693	CcSEcCtD
Dantrolene—Feeling abnormal—Epirubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Dantrolene—Somnolence—Doxorubicin—testicular cancer	0.000681	0.000681	CcSEcCtD
Dantrolene—Gastrointestinal pain—Epirubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—testicular cancer	0.000674	0.000674	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—testicular cancer	0.000661	0.000661	CcSEcCtD
Dantrolene—Urticaria—Epirubicin—testicular cancer	0.000658	0.000658	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Dantrolene—Pain—Doxorubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Dantrolene—Abdominal pain—Epirubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Dantrolene—Body temperature increased—Epirubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—testicular cancer	0.000652	0.000652	CcSEcCtD
Dantrolene—Asthenia—Methotrexate—testicular cancer	0.000635	0.000635	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Dantrolene—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000627	0.000627	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—testicular cancer	0.000626	0.000626	CcSEcCtD
Dantrolene—Hypersensitivity—Epirubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—testicular cancer	0.000609	0.000609	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—testicular cancer	0.000605	0.000605	CcSEcCtD
Dantrolene—Asthenia—Epirubicin—testicular cancer	0.000594	0.000594	CcSEcCtD
Dantrolene—Pruritus—Epirubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Dantrolene—Dizziness—Methotrexate—testicular cancer	0.000585	0.000585	CcSEcCtD
Dantrolene—Diarrhoea—Epirubicin—testicular cancer	0.000567	0.000567	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—testicular cancer	0.000565	0.000565	CcSEcCtD
Dantrolene—Vomiting—Methotrexate—testicular cancer	0.000563	0.000563	CcSEcCtD
Dantrolene—Rash—Methotrexate—testicular cancer	0.000558	0.000558	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—testicular cancer	0.000557	0.000557	CcSEcCtD
Dantrolene—Headache—Methotrexate—testicular cancer	0.000554	0.000554	CcSEcCtD
Dantrolene—Asthenia—Doxorubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Dantrolene—Dizziness—Epirubicin—testicular cancer	0.000548	0.000548	CcSEcCtD
Dantrolene—Pruritus—Doxorubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Dantrolene—Vomiting—Epirubicin—testicular cancer	0.000527	0.000527	CcSEcCtD
Dantrolene—Nausea—Methotrexate—testicular cancer	0.000526	0.000526	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—testicular cancer	0.000524	0.000524	CcSEcCtD
Dantrolene—Rash—Epirubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Dantrolene—Dermatitis—Epirubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Dantrolene—Headache—Epirubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Dantrolene—Dizziness—Doxorubicin—testicular cancer	0.000507	0.000507	CcSEcCtD
Dantrolene—Nausea—Epirubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Dantrolene—Rash—Doxorubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Dantrolene—Headache—Doxorubicin—testicular cancer	0.00048	0.00048	CcSEcCtD
Dantrolene—Nausea—Doxorubicin—testicular cancer	0.000455	0.000455	CcSEcCtD
